Vincent Medical Holdings Limited (HKG:1612)
Hong Kong · Delayed Price · Currency is HKD 0.6300
-0.0100 (-1.56%)
Jul 16, 2025, 3:56 PM HKT
Vincent Medical Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 800.96 | 717.97 | 629.24 | 777.72 | 1,155 | Upgrade | |
Revenue Growth (YoY) | 11.56% | 14.10% | -19.09% | -32.69% | 130.06% | Upgrade |
Cost of Revenue | 540.97 | 477.59 | 463.89 | 518.62 | 661.15 | Upgrade |
Gross Profit | 259.99 | 240.39 | 165.35 | 259.1 | 494.24 | Upgrade |
Selling, General & Admin | 151.2 | 138 | 133.65 | 125.42 | 160.42 | Upgrade |
Research & Development | 30.6 | 36.06 | 36.68 | 39.25 | 36.58 | Upgrade |
Other Operating Expenses | -2.24 | -0.64 | -3.44 | 7.24 | -17.29 | Upgrade |
Operating Expenses | 182.18 | 174.51 | 166.89 | 171.9 | 179.71 | Upgrade |
Operating Income | 77.82 | 65.88 | -1.54 | 87.2 | 314.53 | Upgrade |
Interest Expense | -1.36 | -1.68 | -2.85 | -2.43 | -3.4 | Upgrade |
Interest & Investment Income | 1.2 | 0.7 | 0.51 | 0.38 | 0.23 | Upgrade |
Earnings From Equity Investments | -0.33 | 2.82 | -1.66 | -5.88 | -4.75 | Upgrade |
Currency Exchange Gain (Loss) | 2.87 | 0.48 | -5.77 | 0.81 | -8.74 | Upgrade |
EBT Excluding Unusual Items | 80.2 | 68.2 | -11.31 | 80.08 | 297.87 | Upgrade |
Gain (Loss) on Sale of Investments | -1.15 | -1.66 | -3.82 | -10.73 | -7.06 | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.45 | 0.62 | -2.26 | - | Upgrade |
Asset Writedown | -1.07 | -0.08 | -1.01 | -0.92 | -6.73 | Upgrade |
Pretax Income | 77.98 | 66.92 | -15.52 | 66.18 | 284.08 | Upgrade |
Income Tax Expense | 7.08 | 8.71 | 2.87 | 6.11 | 36.65 | Upgrade |
Earnings From Continuing Operations | 70.9 | 58.21 | -18.39 | 60.07 | 247.44 | Upgrade |
Minority Interest in Earnings | -1.73 | -0.93 | 0.99 | 0.63 | -30.57 | Upgrade |
Net Income | 69.17 | 57.28 | -17.4 | 60.7 | 216.87 | Upgrade |
Net Income to Common | 69.17 | 57.28 | -17.4 | 60.7 | 216.87 | Upgrade |
Net Income Growth | 20.76% | - | - | -72.01% | 1781.69% | Upgrade |
Shares Outstanding (Basic) | 643 | 646 | 654 | 654 | 641 | Upgrade |
Shares Outstanding (Diluted) | 643 | 646 | 654 | 661 | 651 | Upgrade |
Shares Change (YoY) | -0.36% | -1.24% | -1.12% | 1.49% | 2.16% | Upgrade |
EPS (Basic) | 0.11 | 0.09 | -0.03 | 0.09 | 0.34 | Upgrade |
EPS (Diluted) | 0.11 | 0.09 | -0.03 | 0.09 | 0.33 | Upgrade |
EPS Growth | 21.20% | - | - | -72.42% | 1741.87% | Upgrade |
Free Cash Flow | -20.98 | 93.34 | 57.16 | 94.1 | 152.29 | Upgrade |
Free Cash Flow Per Share | -0.03 | 0.14 | 0.09 | 0.14 | 0.23 | Upgrade |
Dividend Per Share | 0.033 | 0.028 | - | 0.045 | 0.110 | Upgrade |
Dividend Growth | 20.00% | - | - | -59.09% | 900.00% | Upgrade |
Gross Margin | 32.46% | 33.48% | 26.28% | 33.32% | 42.78% | Upgrade |
Operating Margin | 9.71% | 9.18% | -0.24% | 11.21% | 27.22% | Upgrade |
Profit Margin | 8.63% | 7.98% | -2.77% | 7.80% | 18.77% | Upgrade |
Free Cash Flow Margin | -2.62% | 13.00% | 9.09% | 12.10% | 13.18% | Upgrade |
EBITDA | 99.6 | 88.07 | 22.21 | 111.65 | 335.71 | Upgrade |
EBITDA Margin | 12.43% | 12.27% | 3.53% | 14.36% | 29.06% | Upgrade |
D&A For EBITDA | 21.78 | 22.19 | 23.74 | 24.44 | 21.18 | Upgrade |
EBIT | 77.82 | 65.88 | -1.54 | 87.2 | 314.53 | Upgrade |
EBIT Margin | 9.71% | 9.18% | -0.24% | 11.21% | 27.22% | Upgrade |
Effective Tax Rate | 9.08% | 13.01% | - | 9.23% | 12.90% | Upgrade |
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.